Hensoldt's Record Order Book and Dividend Hike Gain Shareholder Backing, but a Legal Setback and Analyst Caution Check the Rally

Hensoldt shareholders back 10% dividend increase and strategy, as record €9.8B backlog fuels stock rally but legal challenge and analyst split raise caution.

Hensoldt shareholders gave the defence electronics group's management an emphatic vote of confidence at Friday's virtual annual general meeting, approving a 10% dividend increase to €0.55 per share and ratifying the board's strategy. With 67.11% of the voting capital represented, the AGM also endorsed the compensation report for 2025 with a 92.83% majority and appointed KPMG as auditor for 2026. The smooth approval came against a backdrop of stellar operational numbers—but also a brewing legal storm and a split among analysts over whether the stock's recent surge is justified.

The company's first-quarter performance underscored the strength of its order pipeline. New orders hit €1.483 billion, more than double the year-ago level, while revenue climbed 26% to €496 million and adjusted EBITDA rose 47% to €44 million, pushing the margin to 8.9%. The order backlog swelled to a record €9.8 billion, a figure management says secures capacity utilisation well into the 2030s. A recently awarded Canadian contract for spare parts for the Leopard 2 main battle tank's optronics added nearly €10 million to that pile. For the full year, Hensoldt reaffirmed its target of around €2.75 billion in sales.

That operational momentum has fuelled a powerful rally in the shares. Over the past seven trading sessions, the stock surged roughly 19%, closing Friday at €88.06 (or €88.00 in some data feeds)—fractionally positive on the day. The move has lifted the stock 15.18% since the start of 2026 and taken it comfortably above both the 50-day moving average of €77.72 and the 200-day line at €83.81. The relative strength index stands at 55.4, a neutral reading that suggests the market hasn't yet reached overbought territory.

Yet the rally has stirred a sharp debate among analysts. mwb research maintains a sell rating, arguing the share price move lacks fundamental justification. In contrast, Deutsche Bank reiterates its buy recommendation with a €101 price target, while Jefferies and Warburg Research are also bullish at €90 and €91 respectively. With a market capitalisation of roughly €10.2 billion, Hensoldt's valuation now sits at a premium that supporters say reflects the unique visibility offered by the €9.8 billion backlog, but sceptics counter that earnings per share remain negative—improving from minus €0.26 to minus €0.16 in Q1.

Adding a layer of uncertainty, a regional court in Düsseldorf has cast doubt on a key plank of Germany's new Bundeswehr procurement acceleration law. The Higher Regional Court ruled that the law's provision stripping appeals of suspensive effect in contract award disputes is likely unconstitutional, citing a violation of effective legal protection. The case now moves to the Federal Constitutional Court, a process that could drag on for months. For Hensoldt, which had counted on faster order processing under the new rules, the ruling threatens to slow the very momentum the record backlog is meant to deliver.

All eyes now turn to the second-quarter results, due on 31 July 2026, for evidence that the record order intake is translating into bottom-line improvement. In the near term, the stock faces the psychological resistance of €90. After a near-19% weekly jump, a consolidation phase would be unsurprising. The technical setup remains constructive, but the interplay between a booming order book, a divided analyst community, and a legal challenge to procurement speed will likely define the next leg for Hensoldt's shares.